Schoenberg Mark (CIK 1763581) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-09). Recent activity: Buy URGN (1,667 shares), Sell URGN (871 shares), Sell URGN (60,677 shares), Sell URGN (10,000 shares), Sell URGN (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 1,667 | $0 |
| 2026-09-09 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 871 | $37,383 |
| 2026-08-24 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 60,677 | $2.9M |
| 2026-07-10 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 10,000 | $400,000 |
| 2026-06-24 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 10,000 | $350,100 |
| 2026-06-09 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 10,000 | $0 |
| 2026-06-09 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 5,222 | $142,561 |
| 2026-05-11 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 10,000 | $300,000 |
| 2026-02-04 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 1,844 | $36,308 |
| 2026-02-04 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 1,843 | $36,289 |
| 2026-02-04 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 3,686 | $72,577 |
| 2026-02-03 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 3,333 | $0 |
| 2026-02-03 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 6,666 | $0 |
| 2026-02-03 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 3,334 | $0 |
| 2025-11-20 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 10,000 | $250,000 |
| 2025-09-09 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 1,667 | $0 |
| 2025-09-09 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 871 | $16,645 |
| 2025-08-13 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 10,000 | $176,900 |
| 2025-07-30 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 10,000 | $0 |
| 2025-07-30 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 5,149 | $98,552 |
| 2025-06-11 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Buy | 10,000 | $0 |
| 2025-06-11 | UroGen Pharma Ltd. (URGN) | Chief Medical Officer | Sell | 5,162 | $38,044 |
来源：SEC Form 4 申报文件 · 截至 2026-09-09